Mutations in SETD2 cause a novel overgrowth condition
暂无分享,去创建一个
R. Touraine | E. Pasmant | M. Vidaud | I. Laurendeau | D. Lacombe | F. Giuliano | A. Luscan | V. Cormier-Daire | S. Odent | C. Francannet | V. Malan | É. Pasmant
[1] Katrina Tatton-Brown,et al. Mutations in the DNA methyltransferase gene, DNMT3A, cause an overgrowth syndrome with intellectual disability , 2014, Nature Genetics.
[2] Yuchen Jiao,et al. Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas , 2014, Genes, chromosomes & cancer.
[3] N. Rahman,et al. The NSD1 and EZH2 Overgrowth Genes, Similarities and Differences , 2013, American journal of medical genetics. Part C, Seminars in medical genetics.
[4] David T. W. Jones,et al. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas , 2013, Acta Neuropathologica.
[5] Yoo Jin Jung,et al. The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.
[6] C. Bountra,et al. Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.
[7] E. Greer,et al. Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.
[8] L. Zitvogel,et al. Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.
[9] E. Wagner,et al. Understanding the language of Lys36 methylation at histone H3 , 2012, Nature Reviews Molecular Cell Biology.
[10] Steven J. M. Jones,et al. Mutations in EZH2 cause Weaver syndrome. , 2012, American journal of human genetics.
[11] E. di Luccio,et al. Cancers and the NSD family of histone lysine methyltransferases. , 2011, Biochimica et biophysica acta.
[12] Paul Flicek,et al. The functional spectrum of low-frequency coding variation , 2011, Genome Biology.
[13] Nada Jabado,et al. What can exome sequencing do for you? , 2011, Journal of Medical Genetics.
[14] D. Reinberg,et al. The Polycomb complex PRC2 and its mark in life , 2011, Nature.
[15] B. Zhu,et al. H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation* , 2011, The Journal of Biological Chemistry.
[16] D. Reinberg,et al. The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation* , 2010, The Journal of Biological Chemistry.
[17] K. Mokbel,et al. Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. , 2010, Anticancer research.
[18] Gerben Duns,et al. Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. , 2010, Cancer research.
[19] Hong Li,et al. Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling , 2010, Proceedings of the National Academy of Sciences.
[20] J. Ahringer,et al. Differential chromatin marking of introns and expressed exons by H3K36me3 , 2008, Nature Genetics.
[21] K. Jones,et al. The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation. , 2008, Genes & development.
[22] L. Mahadevan,et al. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation , 2007, The EMBO journal.
[23] V. Cormier-Daire,et al. Sotos syndrome , 2007, Orphanet journal of rare diseases.
[24] T. Mikkelsen,et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.
[25] N. Rahman,et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth , 2007, Nature Genetics.
[26] Dustin E. Schones,et al. High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.
[27] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[28] Bing Li,et al. Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription , 2005, Cell.
[29] A. Munnich,et al. Clinical and molecular overlap in overgrowth syndromes , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.
[30] Xing Zhang,et al. The SET-domain protein superfamily: protein lysine methyltransferases , 2005, Genome Biology.
[31] N. Rahman,et al. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. , 2005, American journal of human genetics.
[32] A. Munnich,et al. Spectrum of NSD1 mutations in Sotos and Weaver syndromes , 2003, Journal of medical genetics.
[33] J. Cheng,et al. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. , 2001, Blood.
[34] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[35] T. Cole,et al. Sotos syndrome: a study of the diagnostic criteria and natural history. , 1994, Journal of medical genetics.
[36] T. Cole,et al. Small cell lung carcinoma in a patient with Sotos syndrome: are genes at 3p21 involved in both conditions? , 1992, Journal of medical genetics.
[37] J. Fryns,et al. Sotos syndrome and de novo balanced autosomal translocation (t(3;6)(p21;p21)) , 1990, Clinical genetics.
[38] David W. Smith,et al. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. , 1974, The Journal of pediatrics.
[39] J. Crawford,et al. Cerebral Gigantism in Childhood , 1964 .
[40] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[41] N. Rahman,et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. , 2003, American journal of human genetics.
[42] 黒滝 直弘. 私の論文から Haploinsufficiency of NSD1 causes Sotos syndrome , 2003 .
[43] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[44] J. Crawford,et al. CEREBRAL GIGANTISM IN CHILDHOOD. A SYNDROME OF EXCESSIVELY RAPID GROWTH AND ACROMEGALIC FEATURES AND A NONPROGRESSIVE NEUROLOGIC DISORDER. , 1964, The New England journal of medicine.